ChemWerth Forms Joint-VentureChemWerth augments its core competency as a product development company by forming a Joint Venture in China: ChemWerth and Tianjin Weijie Technology Co., Ltd of Tianjin, China partnered to develop and scale-up processes for API manufacturing. Tianjin WeiJie-chemwerth Science and Technology Co. Ltd. established three separate workshops with multiple chemists per unit. The JV will result in a minimum of 12 projects per year. This exciting partnership positions ChemWerth to select and manage custom synthesis projects, creating a distinct advantage over the competition. For companies using API for generic drug launch and alternate source work, new drug compound development, key intermediate sourcing and contract finished dosage forms; this JV Company will enable unprecedented speed to market - providing one more reason to choose ChemWerth!
<< Return to ChemWerth News
|
|